|
C5ORF43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.760600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.440800E-03 |
| Normal-vs-Stage2 |
2.739400E-01 |
| Normal-vs-Stage3 |
1.352320E-04 |
| Normal-vs-Stage4 |
3.52079999998978E-06 |
| Stage1-vs-Stage2 |
1.158620E-01 |
| Stage1-vs-Stage3 |
1.015990E-01 |
| Stage1-vs-Stage4 |
1.296070E-02 |
| Stage2-vs-Stage3 |
1.799580E-02 |
| Stage2-vs-Stage4 |
2.283700E-03 |
| Stage3-vs-Stage4 |
2.833600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.4456000000026E-05 |
| Normal-vs-AfricanAmerican |
2.670100E-02 |
| Normal-vs-Asian |
1.060230E-02 |
| Caucasian-vs-AfricanAmerican |
8.302800E-01 |
| Caucasian-vs-Asian |
3.741200E-01 |
| AfricanAmerican-vs-Asian |
7.239200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.578500E-04 |
| Normal-vs-Female |
6.788700E-04 |
| Male-vs-Female |
7.388800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.221700E-03 |
| Normal-vs-Age(41-60Yrs) |
6.049900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.759230E-04 |
| Normal-vs-Age(81-100Yrs) |
2.172600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.891800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.852000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.097200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.386400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.406600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.843600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.551900E-02 |
| Classical-VS-Follicular |
9.243700E-02 |
| Classical-VS-Other |
9.274000E-01 |
| Classical-VS-Normal |
9.597100E-04 |
| Tall-VS-Follicular |
6.257400E-03 |
| Tall-VS-Other |
2.987800E-01 |
| Tall-VS-Normal |
7.8505000000062E-05 |
| Follicular-VS-Other |
5.698000E-01 |
| Follicular-VS-Normal |
1.331420E-01 |
| Other-VS-Normal |
1.850810E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.617700E-03 |
| Normal-vs-N1 |
6.44650000000135E-05 |
| N0-vs-N1 |
1.156040E-01 |
|
|
